We have recently demonstrated that airway eosinophilic inflammation can be transferred to unprimed mice by infusion of IL-5-producing T cell clones. In this study, we investigated the effects of dexamethasone and cyclosporin A on the airway eosinophilic inflammation in mice transferred with T cell clones. An ovalbumin-reactive T cell clone, KW29, produced IL-5 as well as IL-2 and IL-4 upon stimulation with relevant antigen. Dexamethasone and cyclosporin A dose-dependently suppressed the production of these cytokines in vitro. The number of eosinophils recovered in the bronchoalveolar lavage fluid and the airway responsiveness to acetylcholine were increased in KW29-transferred mice after antigen provocation. Both responses were dose-dependently suppressed by the administration of dexamethasone or cyclosporin A in vivo. We concluded that airway eosinophilic inflammation can be controlled by agents capable of downregulating IL-5 production in T cells.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000053566DOI Listing

Publication Analysis

Top Keywords

dexamethasone cyclosporin
16
airway eosinophilic
12
eosinophilic inflammation
12
cell clones
8
dose-dependently suppressed
8
airway
5
il-5-producing cells
4
cells induce
4
induce airway
4
airway eosinophilia
4

Similar Publications

Hemophagocytic lymphohistiocytosis (HLH), is a fatal systemic hyperinflammatory syndrome. HLH may be due to immunosuppression, infections, cancer, or autoimmune diseases with fever and cytopenia. HLH which occurs in adult-onset Stills disease (AOSD) is called secondary HLH, also known as macrophage activation syndrome (MAS).

View Article and Find Full Text PDF

Objectives: To compare the efficacy of 0.05% cyclosporine A (CsA) eye drops (II) and 3% Diquafosol ophthalmic solution (DQS) in the treatment of dry eye (DE) after cataract surgery (CS).

Methods: Clinical data of 123 patients with DE after CS treated at the Fourth Hospital of Hebei Medical University from June 2022 to August 2023 were retrospectively analyzed.

View Article and Find Full Text PDF

To systematically evaluate clinical features and effects of cyclosporine in the treatment of psoriasis. Databases including Web of Science, PubMed, The Cochrane Library, Embase, CNKI, Wan Fang, and VIP were electronically searched for studies on the use of cyclosporine in the treatment of psoriasis, from inception to March 2024. Two reviewers independently screened the literature, extracted data, and assessed the risk of bias of the included studies.

View Article and Find Full Text PDF

Background: To assess the effectiveness of the combination of dexamethasone, rituximab, and cyclosporine in treating adults with primary immune thrombocytopenia (ITP).

Research Design And Methods: This prospective study enrolled consecutive adult patients diagnosed with ITP at the 967th Hospital of the Chinese People's Liberation Army Joint Service Support Force Hospital between November 2019 and February 2023.

Results: Twenty-eight patients (13 males, median age 43.

View Article and Find Full Text PDF

[Deflazacort-induced Steven-Johnson syndrome: a case report and literature review].

Zhonghua Er Ke Za Zhi

November 2024

Department of Rheumatology & Clinical Immunology, Tianjin Children's Hospital, Tianjin 300134, China.

Article Synopsis
  • The study aimed to highlight the clinical features and outcomes of Steven Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) caused by deflazacort, particularly for patients with Duchenne muscular dystrophy (DMD) and healthcare professionals.
  • A 12-year-old boy with DMD developed SJS after switching from prednisolone to deflazacort, presenting with severe skin and mucosal symptoms.
  • Treatment included intravenous immunoglobulin (IVIG) and corticosteroids, leading to complete remission, and a literature review revealed a total of 7 male patients reported with similar conditions related to deflazacort.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!